LEGISLATIVE BUDGET BOARD

Austin, Texas

FISCAL NOTE, 78TH LEGISLATIVE REGULAR SESSION

April 9, 2003

TO:	Honorable Jaime Capelo, Chair, House Committee on Public Health
FROM:	John Keel, Director, Legislative Budget Board
IN RE:	HB1891 by Zedler (Relating to the labeling of certain drugs.), As Introduced

No fiscal implication to the State is anticipated.

This bill would repeal several sections of the Health and Safety Code relating to labeling requirements for prescription drugs.  The bill would revise provisions of the Texas Food, Drug, and Cosmetic Act to conform to the labeling requirements for prescription drugs as required by the federal government under the Federal Food, Drug, and Cosmetic Act.  

 

This bill would take effect September 1, 2003.

Local Government Impact

No fiscal implication to units of local government is anticipated.

Source Agencies:	501 Department of Health
LBB Staff:	JK, EB, KF, MH